EPISODE · Nov 27, 2025 · 13 MIN
Sleep Apnea Significantly Impacts Mortality Benefit of GLP-1s - report from CHEST 2025
from Medical Digest & Congress Report · host Medical Congress News
Dr. Cosmo Fowler explains thet data revealed one-year mortality in patients with type 2 diabetes prescribed GLP-1 RAs was substantially lower than those not prescribed the drugs, and disproportionate benefit for those also diagnosed with OSA. The results were presented at the American College of Chest Physicians (CHEST) 2025 Annual Meeting.Video: https://medicaldigest.org/scientific-contents/interview:sleep-apnea-significantly-impacts-mortality-benefit-glp-1s
Embed this episode
NOW PLAYING
Sleep Apnea Significantly Impacts Mortality Benefit of GLP-1s - report from CHEST 2025
No transcript for this episode yet
Similar Episodes
Similar Podcasts
No similar podcasts found.